XNAS: MBRX
Moleculin Biotech Inc Live Stock Price Today, Share Analysis and Chart
about
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline ...
Read More
2.07
-0.09
(-4.17%)
62,897.3
XNAS Volume
XNAS 18 Mar, 2026 1:37 PM (EDT)
Board Meeting
The next board meeting for Moleculin Biotech Inc is on 24 Mar 2026 for the purpose of Moleculin Biotech Inc Fourth Quarter Earnings Conference Call for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Moleculin Biotech Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..